对话复星联合健康保险赖晓辉：推动社商融合，能让老百姓用上创新药

Core Insights - The 2025 Sustainable Global Leaders Conference will be held from October 16 to 18 in Shanghai, focusing on the integration of social security and commercial insurance to promote access to innovative drugs for the general public [1][3]. Group 1: Impact of AI on Innovative Drugs and Insurance - AI technology is enhancing the efficiency of innovative drug development, which allows more people to access these drugs [3]. - The accessibility of innovative drugs is a primary concern, ensuring that the public is aware of and can afford these medications [3]. Group 2: Challenges in the Chinese Pharmaceutical Market - Chinese pharmaceutical companies are leading in innovative drug development globally, but many rely on overseas markets for expansion [3]. - High research and development costs of innovative drugs lead to expensive sales, creating barriers for the general public to access these medications, especially under the current cost-control environment of China's healthcare system [3][4]. Group 3: Solutions for Improving Access to Innovative Drugs - The role of commercial insurance is crucial in addressing the accessibility issues of innovative drugs [4]. - There is a need for the integration of social security and commercial insurance, with ongoing research by the National Medical Insurance Center to innovate the catalog of commercial health insurance for innovative drugs [4].